BCL2L11 and non-small cell lung carcinoma: As predicted, SCLC cells are significantly more primed to apoptosis than NSCLC cells in response to dinaciclib as shown by an increased delta priming (Δ% priming) upon treatment with the BIM peptide (Fig. 1G).